Stanley Phillips, DPM
Foot Surgery · American Fork, UTNPI 1841202397
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Stryker at 55.5% of the total. Reporting peaked in 2020 at $384 and has fallen 85.6% since, to $55 in 2025.
Across 36 payments — averaging $24.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$484
- Smith+Nephew$143
- KCI USA, Inc.$83
- Bioventus LLC$30
- Medline Industries LP$28
- AbbVie$27
- plus $78 from 4 others
What the payments were for
- Food & beverage$871100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 15 | $484 |
| Smith+Nephew | 8 | $143 |
| KCI USA, Inc. | 4 | $83 |
| Bioventus LLC | 2 | $30 |
| Medline Industries LP | 2 | $28 |
| AbbVie | 1 | $27 |
| Integra Lifesciences Corporation | 1 | $23 |
| Vericel Corporation | 1 | $21 |
| Triad Life Sciences Inc. | 1 | $21 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VARIAX$132
How this compares
Too few foot surgery providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 21 | $3,218 |
| Linezolid | 11 | $1,061 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 61 | $879 |
| Cephalexin | 86 | $829 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 66 | $388 |
| Terbinafine Hcl | 31 | $310 |
| Methylprednisolone | 18 | $152 |
| Meloxicam | 21 | $90 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in American Fork
- Trevor WilliamsWest Jordan$42K
- Ryan EllsworthSalt Lake City$5K
- Terry CookMontezuma Creek$2K
- William MartinLogan$2K
- Jon YoungTaylorsville$312
- Gary ChambersPrice$167
- Jack DavisFarr West$14
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.